Sort   by:  
 Page size 
ProteomicsGenerative Deep Learning Pipeline Yields Potent Gram-negative Antibiotics
The escalating crisis of multiresistant bacteria demands the rapid discovery of novel antibiotics that transcend the limitations imposed by the biased chemical space of current libraries. To address this challenge, we introduce an innovative deep learning-driven pipeline for de novo antibiotic desig...
ORGANISM(S): Escherichia coli 
2025-10-06 | PXD066005 | Pride
Machine learning Deep learning Antibiotics Drug discovery Mrsa Automated synthesis De novo drug design Gram-negative 
Sort   by:  
 Page size